Selected research
Industry Research
Mebeverine Industry Research Report 2026
Market perspective
The global Mebeverine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mebeverine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mebeverine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mebeverine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mebeverine include Aurovitas Pharma, Berlin Pharmaceutical, Dr. Reddy's, Eipico Pharmaceutical, Expanscience, Greville Investing Limited, Pharco, Puren Pharma and Sopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mebeverine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mebeverine Market by Company
Aurovitas Pharma
Berlin Pharmaceutical
Dr. Reddy's
Eipico Pharmaceutical
Expanscience
Greville Investing Limited
Pharco
Puren Pharma
Sopharma
Swiss Pharm
USV Private Limited
Mylan
Abbott
Mebeverine Segment by Type
Capsule
Tablet
Mebeverine Segment by Application
On-line
Drug Store
Hospital
Mebeverine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebeverine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebeverine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebeverine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mebeverine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mebeverine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mebeverine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
Applications
- On-line
- Drug Store
- Hospital
Companies covered
- Aurovitas Pharma
- Berlin Pharmaceutical
- Dr. Reddy's
- Eipico Pharmaceutical
- Expanscience
- Greville Investing Limited
- Pharco
- Puren Pharma
- Sopharma
- Swiss Pharm
- USV Private Limited
- Mylan
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mebeverine Market Size (2021-2032)
- 2.2.2 Global Mebeverine Sales (2021-2032)
- 2.2.3 Global Mebeverine Market Average Price (2021-2032)
- 2.3 Mebeverine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.4 Mebeverine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 On-line
- 2.4.3 Drug Store
- 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mebeverine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mebeverine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Mebeverine Revenue of Manufacturers (2021-2026)
- 3.4 Global Mebeverine Average Price by Manufacturers (2021-2026)
- 3.5 Global Mebeverine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mebeverine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mebeverine, Product Type & Application
- 3.8 Global Manufacturers of Mebeverine, Established Date
- 3.9 Global Mebeverine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aurovitas Pharma
- 4.1.1 Aurovitas Pharma Company Information
- 4.1.2 Aurovitas Pharma Business Overview
- 4.1.3 Aurovitas Pharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aurovitas Pharma Mebeverine Product Portfolio
- 4.1.5 Aurovitas Pharma Recent Developments
- 4.2 Berlin Pharmaceutical
- 4.2.1 Berlin Pharmaceutical Company Information
- 4.2.2 Berlin Pharmaceutical Business Overview
- 4.2.3 Berlin Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Berlin Pharmaceutical Mebeverine Product Portfolio
- 4.2.5 Berlin Pharmaceutical Recent Developments
- 4.3 Dr. Reddy's
- 4.3.1 Dr. Reddy's Company Information
- 4.3.2 Dr. Reddy's Business Overview
- 4.3.3 Dr. Reddy's Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy's Mebeverine Product Portfolio
- 4.3.5 Dr. Reddy's Recent Developments
- 4.4 Eipico Pharmaceutical
- 4.4.1 Eipico Pharmaceutical Company Information
- 4.4.2 Eipico Pharmaceutical Business Overview
- 4.4.3 Eipico Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eipico Pharmaceutical Mebeverine Product Portfolio
- 4.4.5 Eipico Pharmaceutical Recent Developments
- 4.5 Expanscience
- 4.5.1 Expanscience Company Information
- 4.5.2 Expanscience Business Overview
- 4.5.3 Expanscience Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Expanscience Mebeverine Product Portfolio
- 4.5.5 Expanscience Recent Developments
- 4.6 Greville Investing Limited
- 4.6.1 Greville Investing Limited Company Information
- 4.6.2 Greville Investing Limited Business Overview
- 4.6.3 Greville Investing Limited Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Greville Investing Limited Mebeverine Product Portfolio
- 4.6.5 Greville Investing Limited Recent Developments
- 4.7 Pharco
- 4.7.1 Pharco Company Information
- 4.7.2 Pharco Business Overview
- 4.7.3 Pharco Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pharco Mebeverine Product Portfolio
- 4.7.5 Pharco Recent Developments
- 4.8 Puren Pharma
- 4.8.1 Puren Pharma Company Information
- 4.8.2 Puren Pharma Business Overview
- 4.8.3 Puren Pharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Puren Pharma Mebeverine Product Portfolio
- 4.8.5 Puren Pharma Recent Developments
- 4.9 Sopharma
- 4.9.1 Sopharma Company Information
- 4.9.2 Sopharma Business Overview
- 4.9.3 Sopharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sopharma Mebeverine Product Portfolio
- 4.9.5 Sopharma Recent Developments
- 4.10 Swiss Pharm
- 4.10.1 Swiss Pharm Company Information
- 4.10.2 Swiss Pharm Business Overview
- 4.10.3 Swiss Pharm Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Swiss Pharm Mebeverine Product Portfolio
- 4.10.5 Swiss Pharm Recent Developments
- 4.11 USV Private Limited
- 4.11.1 USV Private Limited Company Information
- 4.11.2 USV Private Limited Business Overview
- 4.11.3 USV Private Limited Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 USV Private Limited Mebeverine Product Portfolio
- 4.11.5 USV Private Limited Recent Developments
- 4.12 Mylan
- 4.12.1 Mylan Company Information
- 4.12.2 Mylan Business Overview
- 4.12.3 Mylan Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mylan Mebeverine Product Portfolio
- 4.12.5 Mylan Recent Developments
- 4.13 Abbott
- 4.13.1 Abbott Company Information
- 4.13.2 Abbott Business Overview
- 4.13.3 Abbott Mebeverine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abbott Mebeverine Product Portfolio
- 4.13.5 Abbott Recent Developments
5 Global Mebeverine Market Scenario by Region
- 5.1 Global Mebeverine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mebeverine Sales by Region: 2021-2032
- 5.2.1 Global Mebeverine Sales by Region: 2021-2026
- 5.2.2 Global Mebeverine Sales by Region: 2027-2032
- 5.3 Global Mebeverine Revenue by Region: 2021-2032
- 5.3.1 Global Mebeverine Revenue by Region: 2021-2026
- 5.3.2 Global Mebeverine Revenue by Region: 2027-2032
- 5.4 North America Mebeverine Market Facts & Figures by Country
- 5.4.1 North America Mebeverine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mebeverine Sales by Country (2021-2032)
- 5.4.3 North America Mebeverine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Mebeverine Market Facts & Figures by Country
- 5.5.1 Europe Mebeverine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mebeverine Sales by Country (2021-2032)
- 5.5.3 Europe Mebeverine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Mebeverine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mebeverine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mebeverine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mebeverine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mebeverine Market Facts & Figures by Country
- 5.7.1 South America Mebeverine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mebeverine Sales by Country (2021-2032)
- 5.7.3 South America Mebeverine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Mebeverine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mebeverine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mebeverine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mebeverine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Mebeverine Sales by Type (2021-2032)
- 6.1.1 Global Mebeverine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Mebeverine Sales Market Share by Type (2021-2032)
- 6.2 Global Mebeverine Revenue by Type (2021-2032)
- 6.2.1 Global Mebeverine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mebeverine Revenue Market Share by Type (2021-2032)
- 6.3 Global Mebeverine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mebeverine Sales by Application (2021-2032)
- 7.1.1 Global Mebeverine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Mebeverine Sales Market Share by Application (2021-2032)
- 7.2 Global Mebeverine Revenue by Application (2021-2032)
- 7.2.1 Global Mebeverine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mebeverine Revenue Market Share by Application (2021-2032)
- 7.3 Global Mebeverine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mebeverine Value Chain Analysis
- 8.1.1 Mebeverine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mebeverine Production Mode & Process
- 8.2 Mebeverine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mebeverine Distributors
- 8.2.3 Mebeverine Customers
9 Global Mebeverine Analyzing Market Dynamics
- 9.1 Mebeverine Industry Trends
- 9.2 Mebeverine Industry Drivers
- 9.3 Mebeverine Industry Opportunities and Challenges
- 9.4 Mebeverine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst